Freeman Jonathan E 4
4 · Phio Pharmaceuticals Corp. · Filed Feb 22, 2023
Insider Transaction Report
Form 4
Freeman Jonathan E
Director
Transactions
- Award
Common stock, $0.0001 par value
2023-02-17+1,500→ 3,197 total
Footnotes (2)
- [F1]Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.
- [F2]Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 26, 2023, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-12.